| Year |
Citation |
Score |
| 2024 |
FitzGerald LM, Jung CH, Wong EM, Joo JE, Bassett JK, Dowty JG, Wang X, Dai JY, Stanford JL, O'Callaghan N, Nottle T, Pedersen J, Giles GG, Southey MC. Detection of differentially methylated CpGs between tumour and adjacent benign cells in diagnostic prostate cancer samples. Scientific Reports. 14: 17877. PMID 39095452 DOI: 10.1038/s41598-024-66488-x |
0.374 |
|
| 2024 |
Foley GR, Marthick JR, Lucas SE, Raspin K, Banks A, Stanford JL, Ostrander EA, FitzGerald LM, Dickinson JL. Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants. Cancers. 16. PMID 39001544 DOI: 10.3390/cancers16132482 |
0.437 |
|
| 2023 |
Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, ... ... Stanford JL, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. PMID 37945903 DOI: 10.1038/s41588-023-01534-4 |
0.609 |
|
| 2023 |
Ma C, Wang X, Dai JY, Turman C, Kraft P, Stopsack KH, Loda M, Pettersson A, Mucci LA, Stanford JL, Penney KL. Germline genetic variants associated with somatic TMPRSS2:ERG fusion status in prostate cancer: a genome-wide association study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 37555839 DOI: 10.1158/1055-9965.EPI-23-0275 |
0.564 |
|
| 2023 |
Darst BF, Shen J, Madduri RK, Rodriguez AA, Xiao Y, Sheng X, Saunders EJ, Dadaev T, Brook MN, Hoffmann TJ, Muir K, Wan P, Le Marchand L, Wilkens L, Wang Y, ... ... Stanford JL, et al. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. American Journal of Human Genetics. PMID 37311464 DOI: 10.1016/j.ajhg.2023.05.010 |
0.532 |
|
| 2023 |
Darst BF, Shen J, Madduri RK, Rodriguez AA, Xiao Y, Sheng X, Saunders EJ, Dadaev T, Brook MN, Hoffmann TJ, Muir K, Wan P, Marchand LL, Wilkens L, Wang Y, ... ... Stanford JL, et al. Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry. Medrxiv : the Preprint Server For Health Sciences. PMID 37292833 DOI: 10.1101/2023.05.12.23289860 |
0.531 |
|
| 2023 |
Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, Wang A, Shen J, Saunders EJ, Rhie SK, Bensen JT, Ingles SA, Kittles RA, Strom SS, Rybicki BA, ... ... Stanford JL, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology. PMID 36872133 DOI: 10.1016/j.eururo.2023.01.022 |
0.637 |
|
| 2022 |
Foley GR, Marthick JR, Ostrander EA, Stanford JL, Dickinson JL, FitzGerald LM. Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing. European Journal of Cancer (Oxford, England : 1990). 180: 155-157. PMID 36599183 DOI: 10.1016/j.ejca.2022.11.034 |
0.534 |
|
| 2022 |
Gregg JR, Kim J, Logothetis C, Hanash S, Zhang X, Manyam G, Muir K, Giles GG, Stanford JL, Berndt SI, Kogevinas M, Brenner H, Eeles RA, Wei P, Daniel CR. Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. European Urology Oncology. PMID 35995710 DOI: 10.1016/j.euo.2022.07.008 |
0.57 |
|
| 2022 |
Wang X, Jordahl KM, Zhu C, Livingstone J, Rhie SK, Wright JL, Grady WM, Boutros PC, Stanford JL, Dai JY. Methylation subtypes of primary prostate cancer predict poor prognosis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35437583 DOI: 10.1158/1055-9965.EPI-22-0007 |
0.561 |
|
| 2022 |
Huynh-Le MP, Karunamuni R, Fan CC, Asona L, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir KR, Lophatananon A, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, ... ... Stanford JL, et al. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Prostate Cancer and Prostatic Diseases. PMID 35152271 DOI: 10.1038/s41391-022-00497-7 |
0.652 |
|
| 2022 |
Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, Sheng X, Xia L, Andrews C, Chen F, Berndt SI, Kote-Jarai Z, Govindasami K, Bensen JT, Ingles SA, ... ... Stanford JL, et al. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European Urology. PMID 35031163 DOI: 10.1016/j.eururo.2021.12.023 |
0.618 |
|
| 2022 |
Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, et al. Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. Hgg Advances. 3. PMID 34993496 DOI: 10.1016/j.xhgg.2021.100070 |
0.557 |
|
| 2021 |
Marthick JR, Raspin K, Foley GR, Blackburn NB, Banks A, Donovan S, Malley RC, Field MA, Stanford JL, Ostrander EA, FitzGerald LM, Dickinson JL. Massively parallel sequencing in hereditary prostate cancer families reveals a rare risk variant in the DNA repair gene, RAD51C. European Journal of Cancer (Oxford, England : 1990). 159: 52-55. PMID 34736042 DOI: 10.1016/j.ejca.2021.09.038 |
0.512 |
|
| 2021 |
Salmon C, Song L, Muir K, Pashayan N, Dunning AM, Batra J, Chambers S, Stanford JL, Ostrander EA, Park JY, Lin HY, Cussenot O, Cancel-Tassin G, et al. Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium. European Journal of Epidemiology. PMID 34275018 DOI: 10.1007/s10654-021-00781-1 |
0.598 |
|
| 2021 |
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, Markt SC, Freedman M, Pomerantz M, Lee GM, Rana H, Börnigen D, Rebbeck TR, Huttenhower C, Eeles RA, ... Stanford JL, et al. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. The Prostate. PMID 33956343 DOI: 10.1002/pros.24148 |
0.629 |
|
| 2021 |
Lin HY, Huang PY, Cheng CH, Tung HY, Fang Z, Berglund AE, Chen A, French-Kwawu J, Harris D, Pow-Sang J, Yamoah K, Cleveland JL, Awasthi S, Rounbehler RJ, Gerke T, ... ... Stanford JL, et al. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness. Scientific Reports. 11: 9264. PMID 33927218 DOI: 10.1038/s41598-021-85169-7 |
0.38 |
|
| 2021 |
Raspin K, FitzGerald LM, Marthick JR, Field MA, Malley RC, Banks A, Donovan S, Thomson RJ, Foley GR, Stanford JL, Dickinson JL. A rare variant in EZH2 is associated with prostate cancer risk. International Journal of Cancer. PMID 33821477 DOI: 10.1002/ijc.33584 |
0.594 |
|
| 2021 |
Huynh-Le MP, Fan CC, Karunamuni R, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir K, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Donovan JL, Hamdy FC, ... ... Stanford JL, et al. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. Nature Communications. 12: 1236. PMID 33623038 DOI: 10.1038/s41467-021-21287-0 |
0.585 |
|
| 2021 |
Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Stanford JL, et al. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33473200 DOI: 10.1038/s41588-021-00786-2 |
0.529 |
|
| 2021 |
Karlsson Q, Brook MN, Dadaev T, Wakerell S, Saunders EJ, Muir K, Neal DE, Giles GG, MacInnis RJ, Thibodeau SN, McDonnell SK, Cannon-Albright L, Teixeira MR, Paulo P, Cardoso M, ... ... Stanford JL, et al. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study. European Urology Oncology. PMID 33436325 DOI: 10.1016/j.euo.2020.12.001 |
0.546 |
|
| 2021 |
Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, Schleutker J, Pashayan N, Batra J, Grönberg H, Walsh EI, ... ... Stanford JL, et al. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 33420416 DOI: 10.1038/s41391-020-00311-2 |
0.557 |
|
| 2021 |
Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Stanford JL, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33398198 DOI: 10.1038/s41588-020-00748-0 |
0.597 |
|
| 2020 |
Dai JY, Stanford JL, LeBlanc M. A multiple-testing procedure for high-dimensional mediation hypotheses. Journal of the American Statistical Association. 117: 198-213. PMID 35400115 DOI: 10.1080/01621459.2020.1765785 |
0.319 |
|
| 2020 |
Brandão A, Paulo P, Maia S, Pinheiro M, Peixoto A, Cardoso M, Silva MP, Santos C, Eeles RA, Kote-Jarai Z, Muir K, Ukgpcs Collaborators, Schleutker J, Wang Y, Pashayan N, ... ... Stanford JL, et al. The Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor. Cancers. 12. PMID 33158149 DOI: 10.3390/cancers12113254 |
0.466 |
|
| 2020 |
Schaid DJ, McDonnell SK, FitzGerald LM, DeRycke L, Fogarty Z, Giles GG, MacInnis RJ, Southey MC, Nguyen-Dumont T, Cancel-Tassin G, Cussenot O, Whittemore AS, Sieh W, Ioannidis NM, Hsieh CL, ... Stanford JL, et al. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. European Urology. PMID 32800727 DOI: 10.1016/J.Eururo.2020.07.038 |
0.637 |
|
| 2020 |
Wu L, Yang Y, Guo X, Shu XO, Cai Q, Shu X, Li B, Tao R, Wu C, Nikas JB, Sun Y, Zhu J, Roobol MJ, Giles GG, Brenner H, ... ... Stanford JL, et al. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk. Nature Communications. 11: 3905. PMID 32764609 DOI: 10.1038/S41467-020-17673-9 |
0.35 |
|
| 2020 |
Darst BF, Wan P, Sheng X, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Strom SS, Park JY, Zheng W, ... ... Stanford JL, et al. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. European Urology. PMID 32409115 DOI: 10.1016/J.Eururo.2020.04.060 |
0.538 |
|
| 2020 |
Daugherty SE, Wright JL, Black A, Stanford JL, Hoover R, Berndt SI. Self-reported Prostate Cancer Progression Status Is Accurate: A Validation Study. Epidemiology (Cambridge, Mass.). 31: 441-447. PMID 32251068 DOI: 10.1097/Ede.0000000000001170 |
0.61 |
|
| 2020 |
Dai JY, Wang X, Wang B, Sun W, Jordahl KM, Kolb S, Nyame YA, Wright JL, Ostrander EA, Feng Z, Stanford JL. DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. Plos Genetics. 16: e1008667. PMID 32226005 DOI: 10.1371/Journal.Pgen.1008667 |
0.366 |
|
| 2020 |
Wang X, Grasso CS, Jordahl KM, Kolb S, Nyame YA, Wright JL, Ostrander EA, Troyer DA, Lance R, Feng Z, Dai JY, Stanford JL. Copy number alterations are associated with metastatic-lethal progression in prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 32071439 DOI: 10.1038/S41391-020-0212-8 |
0.568 |
|
| 2020 |
Nyame Y, Wang X, Jordahl K, Dai J, Troyer D, Lance R, Wright J, Stanford J. Pd52-05 Assessing Pam50 Molecular Subtypes By Race And Outcomes In Men With Localized Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000954.05 |
0.529 |
|
| 2019 |
Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich C, Gapstur S, Gaudet M, Coates R, Liff J, Kakouri E, Marcou Y, Duffy S, Morabia A, Schuman L, Stewart W, ... ... Stanford J, et al. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence The Lancet. 394: 1159-1168. PMID 31474332 DOI: 10.1016/S0140-6736(19)31709-X |
0.377 |
|
| 2019 |
Cheng A, Zhao S, FitzGerald LM, Wright JL, Kolb S, Karnes RJ, Jenkins RB, Davicioni E, Ostrander EA, Feng Z, Fan JB, Dai JY, Stanford JL. A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies. The Prostate. PMID 31376183 DOI: 10.1002/Pros.23882 |
0.472 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Stanford JL, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.385 |
|
| 2019 |
Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, ... ... Stanford JL, et al. Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nature Communications. 10: 382. PMID 30655571 DOI: 10.1038/S41467-019-08293-Z |
0.444 |
|
| 2019 |
Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Stanford JL, et al. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 30622367 DOI: 10.1038/S41588-018-0330-6 |
0.423 |
|
| 2018 |
Dai JY, Wang B, Wang X, Cheng A, Kolb S, Stanford JL, Wright JL. Vigorous physical activity is associated with metastatic-lethal progression in prostate cancer and differential tumor DNA methylation in the CRACR2A gene. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30464020 DOI: 10.1158/1055-9965.EPI-18-0622 |
0.519 |
|
| 2018 |
Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, ... ... Stanford JL, et al. Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nature Communications. 9: 4616. PMID 30397198 DOI: 10.1038/S41467-018-06863-1 |
0.634 |
|
| 2018 |
Adams C, Richmond RC, Santos Ferreira DL, Spiller W, Tan VY, Zheng J, Wurtz P, Donovan JL, Hamdy FC, Neal DE, Lane JA, Davey Smith G, Relton CL, Eeles RA, Henderson BE, ... ... Stanford JL, et al. Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30352818 DOI: 10.1158/1055-9965.Epi-18-0079 |
0.589 |
|
| 2018 |
Zhao S, Leonardson A, Geybels MS, McDaniel AS, Yu M, Kolb S, Zong H, Carter K, Siddiqui J, Cheng A, Wright JL, Pritchard CC, Lance R, Troyer D, Fan JB, ... ... Stanford JL, et al. A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. The Prostate. PMID 29956356 DOI: 10.1002/Pros.23667 |
0.451 |
|
| 2018 |
Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, ... ... Stanford JL, et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature Communications. 9: 2256. PMID 29892050 DOI: 10.1038/S41467-018-04109-8 |
0.608 |
|
| 2018 |
Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Stanford JL, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 29892016 DOI: 10.1038/S41588-018-0142-8 |
0.492 |
|
| 2018 |
Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Al Olama AA, Garcia SB, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM, Southey MC, Pharoah P, Pashayan N, Gronberg H, Wiklund F, ... ... Stanford JL, et al. Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium. British Journal of Cancer. PMID 29438364 DOI: 10.1038/bjc.2018.6 |
0.55 |
|
| 2018 |
Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Grönberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, ... Stanford JL, et al. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. British Journal of Cancer. PMID 29438362 DOI: 10.1038/bjc.2017.468 |
0.457 |
|
| 2017 |
Geybels MS, Fang M, Wright JL, Qu X, Bibikova M, Klotzle B, Fan JB, Feng Z, Ostrander EA, Nelson PS, Stanford JL. PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. Oncotarget. 8: 84338-84348. PMID 29137428 DOI: 10.18632/Oncotarget.20940 |
0.413 |
|
| 2017 |
Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, et al. Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. Journal of the National Cancer Institute. 109. PMID 29117387 DOI: 10.1093/Jnci/Djx084 |
0.581 |
|
| 2017 |
Wittmann D, Mehta A, Northouse L, Dunn R, Braun T, Duby A, An L, Arab L, Bangs R, Bober S, Brandon J, Coward M, Dunn M, Galbraith M, Garcia M, ... ... Stanford J, et al. TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial. Bmc Cancer. 17: 664. PMID 28969611 DOI: 10.1186/S12885-017-3652-3 |
0.412 |
|
| 2017 |
Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Olama AAA, Garcia SB, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM, Southey MC, Pharoah P, Pashayan N, Gronberg H, Wiklund F, ... ... Stanford JL, et al. Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium. British Journal of Cancer. PMID 28765617 DOI: 10.1038/Bjc.2017.231 |
0.643 |
|
| 2017 |
Jhun MA, Geybels MS, Wright JL, Kolb S, April C, Bibikova M, Ostrander EA, Fan JB, Feng Z, Stanford JL. Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. Oncotarget. PMID 28496006 DOI: 10.18632/Oncotarget.17428 |
0.39 |
|
| 2017 |
Hoffman RM, Lo M, Clark JA, Albertsen PC, Barry MJ, Goodman M, Penson DF, Stanford JL, Stroup AM, Hamilton AS. Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016706317. PMID 28493812 DOI: 10.1200/Jco.2016.70.6317 |
0.475 |
|
| 2017 |
Larson NB, McDonnell S, Cannon Albright L, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E, Schleutker J, Carpten JD, Powell I, Bailey-Wilson JE, Cussenot O, et al. gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels. Genetic Epidemiology. PMID 28211093 DOI: 10.1002/Gepi.22036 |
0.344 |
|
| 2017 |
Rubicz R, Zhao S, Wright JL, Coleman I, Grasso C, Geybels MS, Leonardson A, Kolb S, April C, Bibikova M, Troyer D, Lance R, Lin DW, Ostrander EA, Nelson PS, ... ... Stanford JL, et al. Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. Molecular Oncology. 11: 140-150. PMID 28145099 DOI: 10.1002/1878-0261.12014 |
0.368 |
|
| 2016 |
Karyadi DM, Geybels MS, Karlins E, Decker B, McIntosh L, Hutchinson A, Kolb S, McDonnell SK, Hicks B, Middha S, FitzGerald LM, DeRycke MS, Yeager M, Schaid DJ, Chanock SJ, ... ... Stanford JL, et al. Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes. Oncotarget. PMID 27902461 DOI: 10.18632/Oncotarget.13646 |
0.454 |
|
| 2016 |
Luedeke M, Rinckleb AE, FitzGerald LM, Geybels MS, Schleutker J, Eeles RA, Teixeira MR, Cannon-Albright L, Ostrander EA, Weikert S, Herkommer K, Wahlfors T, Visakorpi T, Leinonen KA, Tammela TL, ... ... Stanford JL, et al. Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Human Molecular Genetics. PMID 27798103 DOI: 10.1093/Hmg/Ddw349 |
0.432 |
|
| 2016 |
Geybels MS, McCloskey KD, Mills IG, Stanford JL. Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status. The Prostate. PMID 27753122 DOI: 10.1002/pros.23267 |
0.535 |
|
| 2016 |
Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, et al. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. International Journal of Cancer. PMID 27741566 DOI: 10.1002/Ijc.30462 |
0.635 |
|
| 2016 |
Geybels MS, Wright JL, Bibikova M, Klotzle B, Fan JB, Zhao S, Feng Z, Ostrander EA, Lin DW, Nelson PS, Stanford JL. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. Clinical Epigenetics. 8: 97. PMID 27651837 DOI: 10.1186/S13148-016-0260-Z |
0.521 |
|
| 2016 |
Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, ... ... Stanford JL, et al. Alcohol Consumption and Prostate Cancer Incidence and Progression: A Mendelian Randomization Study. International Journal of Cancer. PMID 27643404 DOI: 10.1002/Ijc.30436 |
0.566 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Stanford JL, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.342 |
|
| 2016 |
Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, ... ... Stanford JL, et al. Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. British Journal of Cancer. PMID 27490808 DOI: 10.1038/Bjc.2016.228 |
0.619 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Stanford JL, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.526 |
|
| 2016 |
Rizzardi AE, Zhang X, Vogel RI, Kolb S, Geybels MS, Leung YK, Henriksen JC, Ho SM, Kwak J, Stanford JL, Schmechel SC. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer. Diagnostic Pathology. 11: 63. PMID 27401406 DOI: 10.1186/s13000-016-0511-5 |
0.405 |
|
| 2016 |
Zhao S, Geybels MS, Leonardson A, Rubicz R, Kolb S, Yan Q, Klotzle B, Bibikova M, Hurtado-Coll A, Troyer D, Lance R, Lin D, Wright JL, Ostrander EA, Fan JB, ... ... Stanford JL, et al. Epigenome-wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-lethal Progression in Men with Clinically Localized Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27358489 DOI: 10.1158/1078-0432.Ccr-16-0549 |
0.537 |
|
| 2016 |
Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, ... ... Stanford JL, et al. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. Human Genetics. PMID 27262462 DOI: 10.1007/S00439-016-1690-6 |
0.524 |
|
| 2016 |
Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Davey Smith G, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, ... ... Stanford JL, et al. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels. International Journal of Cancer. 139: 1520-33. PMID 27225428 DOI: 10.1002/Ijc.30206 |
0.474 |
|
| 2016 |
Shui IM, Wong CJ, Zhao S, Kolb S, Ebot EM, Geybels MS, Rubicz R, Wright JL, Lin DW, Klotzle B, Bibikova M, Fan JB, Ostrander EA, Feng Z, Stanford JL. Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. Cancer. PMID 27142338 DOI: 10.1002/Cncr.30045 |
0.408 |
|
| 2016 |
Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, ... ... Stanford JL, et al. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature Communications. 7: 10979. PMID 27052111 DOI: 10.1038/Ncomms10979 |
0.55 |
|
| 2016 |
Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, ... ... Stanford JL, et al. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. Bmc Medicine. 14: 66. PMID 27044414 DOI: 10.1186/S12916-016-0602-X |
0.56 |
|
| 2016 |
Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OH, Richards JB, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, ... ... Stanford JL, et al. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Medicine. 5: 1125-36. PMID 26992435 DOI: 10.1002/Cam4.695 |
0.6 |
|
| 2016 |
Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG, Wiklund F, Grönberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, ... Stanford JL, et al. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. British Journal of Cancer. PMID 26964030 DOI: 10.1038/Bjc.2016.50 |
0.512 |
|
| 2016 |
Rubicz R, Zhao S, Geybels M, Wright JL, Kolb S, Klotzle B, Bibikova M, Troyer D, Lance R, Ostrander EA, Feng Z, Fan JB, Stanford JL. DNA methylation profiles in African American prostate cancer patients in relation to disease progression. Genomics. PMID 26902887 DOI: 10.1016/J.Ygeno.2016.02.004 |
0.505 |
|
| 2016 |
Kent M, Penson DF, Albertsen PC, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Ehdaie B, Scardino PT, Vickers AJ. Successful external validation of a model to predict other cause mortality in localized prostate cancer. Bmc Medicine. 14: 25. PMID 26860993 DOI: 10.1186/S12916-016-0572-Z |
0.523 |
|
| 2016 |
Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Schumacher FR, Berndt SI, Wang Z, Xu J, et al. Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Journal of the National Cancer Institute. 108. PMID 26823525 DOI: 10.1093/Jnci/Djv431 |
0.598 |
|
| 2016 |
Shui IM, Kolb S, Hanson C, Sutcliffe S, Rider JR, Stanford JL. Trichomonas vaginalis infection and risk of advanced prostate cancer. The Prostate. PMID 26818005 DOI: 10.1002/Pros.23153 |
0.634 |
|
| 2016 |
Schade GR, Holt S, Zhang X, Song D, Wright JL, Zhao S, Kolb S, Lam HM, Levin L, Leung YK, Ho SM, Stanford JL. Prostate cancer expression profiles of cytoplasmic ERβ1 and nuclear ERβ2 are associated with poor outcomes following radical prostatectomy. The Journal of Urology. PMID 26804755 DOI: 10.1016/J.Juro.2015.12.101 |
0.399 |
|
| 2016 |
Cropp CD, McDonnell SK, Middha S, DeRycke M, Karyadi DM, Schaid D, Thibodeau SN, Isaacs WB, Ostrander EA, Stanford J, Cooney KA, Bailey-Wilson JE, Carpten JD. Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B40 |
0.563 |
|
| 2015 |
Geybels MS, Alumkal JJ, Luedeke M, Rinckleb A, Zhao S, Shui IM, Bibikova M, Klotzle B, van den Brandt PA, Ostrander EA, Fan JB, Feng Z, Maier C, Stanford JL. Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. Clinical Epigenetics. 7: 128. PMID 26692910 DOI: 10.1186/S13148-015-0161-6 |
0.344 |
|
| 2015 |
Wright JL, Chéry L, Holt S, Lin DW, Luedeke M, Rinckleb AE, Maier C, Stanford JL. Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status. Prostate Cancer and Prostatic Diseases. PMID 26503111 DOI: 10.1038/pcan.2015.49 |
0.535 |
|
| 2015 |
Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, ... ... Stanford JL, et al. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes & Control : Ccc. 26: 1603-16. PMID 26387087 DOI: 10.1007/S10552-015-0654-9 |
0.571 |
|
| 2015 |
Geybels MS, Zhao S, Wong CJ, Bibikova M, Klotzle B, Wu M, Ostrander EA, Fan JB, Feng Z, Stanford JL. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. The Prostate. PMID 26383847 DOI: 10.1002/Pros.23093 |
0.411 |
|
| 2015 |
O'Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, Stanford JL, Stroup AM, Paddock LE, et al. The Comparative Harms of Open and Robotic Prostatectomy in Population-Based Samples. The Journal of Urology. PMID 26343985 DOI: 10.1016/J.Juro.2015.08.092 |
0.404 |
|
| 2015 |
Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald L, Henderson BE, ... ... Stanford JL, et al. Genome-wide association study of prostate cancer-specific survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26307654 DOI: 10.1158/1055-9965.Epi-15-0543 |
0.531 |
|
| 2015 |
Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Henderson BE, Schumacher F, ... ... Stanford JL, et al. Prediction of individual genetic risk to prostate cancer using a polygenic score. The Prostate. 75: 1467-1474. PMID 26177737 DOI: 10.1002/Pros.23037 |
0.63 |
|
| 2015 |
Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, Wang Z, Rand KA, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, ... ... Stanford JL, et al. Integration of Multiethnic Fine-mapping and Genomic Annotation to Prioritize Candidate Functional SNPs at Prostate Cancer Susceptibility Regions. Human Molecular Genetics. PMID 26162851 DOI: 10.1093/Hmg/Ddv269 |
0.428 |
|
| 2015 |
Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, ... ... Stanford JL, et al. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Human Molecular Genetics. PMID 26025378 DOI: 10.1093/Hmg/Ddv203 |
0.399 |
|
| 2015 |
Rubicz R, Zhao S, April C, Wright JL, Kolb S, Coleman I, Lin DW, Nelson PS, Ostrander EA, Feng Z, Fan JB, Stanford JL. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort. The Prostate. PMID 25990700 DOI: 10.1002/Pros.23016 |
0.412 |
|
| 2015 |
Berndt SI, Wang Z, Yeager M, Alavanja MC, Albanes D, Amundadottir L, Andriole G, Beane Freeman L, Campa D, Cancel-Tassin G, Canzian F, Cornu JN, Cussenot O, Diver WR, Gapstur SM, ... ... Stanford JL, et al. Two susceptibility loci identified for prostate cancer aggressiveness. Nature Communications. 6: 6889. PMID 25939597 DOI: 10.1038/Ncomms7889 |
0.612 |
|
| 2015 |
Penney KL, Shui IM, Feng Z, Sesso HD, Stampfer MJ, Stanford JL. Replication of a genetic variant for prostate cancer-specific mortality. Prostate Cancer and Prostatic Diseases. PMID 25939514 DOI: 10.1038/Pcan.2015.18 |
0.56 |
|
| 2015 |
Egbers L, Luedeke M, Rinckleb A, Kolb S, Wright JL, Maier C, Neuhouser ML, Stanford JL. Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status. American Journal of Epidemiology. 181: 706-13. PMID 25852077 DOI: 10.1093/Aje/Kwu344 |
0.574 |
|
| 2015 |
Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, ... ... Stanford JL, et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1121-9. PMID 25837820 DOI: 10.1158/1055-9965.Epi-14-0317 |
0.657 |
|
| 2015 |
Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, ... ... Stanford JL, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9 |
0.452 |
|
| 2015 |
Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, ... ... Stanford JL, et al. A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. Cancer Discovery. 5: 368-79. PMID 25691096 DOI: 10.1158/2159-8290.Cd-14-1057 |
0.592 |
|
| 2015 |
Hoffman RM, Koyama T, Albertsen PC, Barry MJ, Daskivich TJ, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Potosky AL, Penson DF. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. Journal of General Internal Medicine. 30: 924-34. PMID 25678374 DOI: 10.1007/S11606-014-3171-8 |
0.54 |
|
| 2015 |
Morgans AK, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Resnick MJ, Barocas DA, Penson DF. Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy. The Journal of Urology. 193: 1226-31. PMID 25451829 DOI: 10.1016/J.Juro.2014.11.006 |
0.307 |
|
| 2015 |
Panagiotou OA, Travis RC, Campa D, Berndt SI, Lindstrom S, Kraft P, Schumacher FR, Siddiq A, Papatheodorou SI, Stanford JL, Albanes D, Virtamo J, Weinstein SJ, Diver WR, Gapstur SM, et al. A genome-wide pleiotropy scan for prostate cancer risk. European Urology. 67: 649-57. PMID 25277271 DOI: 10.1016/J.Eururo.2014.09.020 |
0.581 |
|
| 2015 |
Karyadi DM, Zhao S, He Q, McIntosh L, Wright JL, Ostrander EA, Feng Z, Stanford JL. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families. International Journal of Cancer. Journal International Du Cancer. 136: 2166-71. PMID 25273821 DOI: 10.1002/Ijc.29241 |
0.562 |
|
| 2015 |
Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF. Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study. Urology. 85: 92-100. PMID 25261048 DOI: 10.1016/J.Urology.2014.07.003 |
0.541 |
|
| 2015 |
Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, et al. Generalizability of established prostate cancer risk variants in men of African ancestry. International Journal of Cancer. Journal International Du Cancer. 136: 1210-7. PMID 25044450 DOI: 10.1002/Ijc.29066 |
0.615 |
|
| 2015 |
Demichelis F, Stanford JL. Genetic predisposition to prostate cancer: Update and future perspectives. Urologic Oncology. 33: 75-84. PMID 24996773 DOI: 10.1016/j.urolonc.2014.04.021 |
0.613 |
|
| 2015 |
Schade GR, Holt SK, Zhang X, Wright JL, Zhao SS, Kolb S, Lam H, Levin L, Leung Y, Ho S, Stanford J. PD47-03 EXPRESSION OF CYTOPLASMIC ERβ1 AND NUCLEAR ERβ2 IS ASSOCIATED WITH POOR OUTCOMES FOLLOWING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2747 |
0.467 |
|
| 2015 |
Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald LM, Henderson BE, Schumacher F, ... ... Stanford JL, et al. Prediction of individual genetic risk to prostate cancer using a polygenic score Prostate. 75: 1467-1474. DOI: 10.1002/pros.23037 |
0.567 |
|
| 2014 |
Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, ... ... Stanford JL, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics. 46: 1103-9. PMID 25217961 DOI: 10.1038/Ng.3094 |
0.656 |
|
| 2014 |
Morgans AK, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Penson DF. Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study. Prostate Cancer and Prostatic Diseases. 17: 338-42. PMID 25134939 DOI: 10.1038/Pcan.2014.31 |
0.533 |
|
| 2014 |
Stott-Miller M, Zhao S, Wright JL, Kolb S, Bibikova M, Klotzle B, Ostrander EA, Fan JB, Feng Z, Stanford JL. Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1331-9. PMID 24718283 DOI: 10.1158/1055-9965.Epi-13-1000 |
0.573 |
|
| 2014 |
Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Severi G, Gronberg H, Aly M, ... ... Stanford JL, et al. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. Plos Genetics. 10: e1004129. PMID 24550738 DOI: 10.1371/Journal.Pgen.1004129 |
0.482 |
|
| 2014 |
Wright JL, Hansten PD, Stanford JL. Is digoxin use for cardiovascular disease associated with risk of prostate cancer? The Prostate. 74: 97-102. PMID 24318956 DOI: 10.1002/pros.22733 |
0.533 |
|
| 2014 |
Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, ... ... Stanford JL, et al. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Human Genetics. 133: 347-56. PMID 24162621 DOI: 10.1007/S00439-013-1384-2 |
0.663 |
|
| 2014 |
Rand KA, Song C, Hwang AE, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Van Den Berg DJ, Sheng X, Graff JJ, Conti DV, Zimmerman T, Peters E, Singhal S, Bock CH, ... ... Stanford J, et al. Genetic Susceptibility Markers of Multiple Myeloma in African-Americans Blood. 124: 2030-2030. DOI: 10.1182/Blood.V124.21.2030.2030 |
0.469 |
|
| 2014 |
Chery L, Wright JL, Lin DW, Qu X, Fang M, Stanford J. MP79-08 PTEN LOSS IN LOCALIZED PROSTATE CANCER: CLINICOPATHOLOGIC PARAMETERS AND RELATIONSHIP WITH DISEASE OUTCOME Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2511 |
0.537 |
|
| 2014 |
Holden L, Stanford J, D'Alimonte L, Kiss A, Loblaw A. Timing variability of bladder volumes in men receiving radiotherapy to the prostate Journal of Medical Imaging and Radiation Sciences. 45: 24-30. DOI: 10.1016/j.jmir.2013.02.001 |
0.438 |
|
| 2013 |
Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Derleth CL, Penson DF. Bone health among prostate cancer survivors: Long-term follow-up from the Prostate Cancer Outcomes Study (PCOS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 106. PMID 28136998 DOI: 10.1200/Jco.2013.31.6_Suppl.106 |
0.464 |
|
| 2013 |
Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Re: Long-term functional outcomes after treatment for localized prostate cancer Journal of Urology. 190: 1764-1765. PMID 24120779 DOI: 10.1016/j.juro.2013.07.084 |
0.453 |
|
| 2013 |
Stott-Miller M, Wright JL, Stanford JL. MSMB gene variant alters the association between prostate cancer and number of sexual partners. The Prostate. 73: 1803-9. PMID 24037734 DOI: 10.1002/pros.22719 |
0.541 |
|
| 2013 |
Holt SK, Kolb S, Fu R, Horst R, Feng Z, Stanford JL. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis. Cancer Epidemiology. 37: 666-70. PMID 23972671 DOI: 10.1016/J.Canep.2013.07.005 |
0.478 |
|
| 2013 |
Geybels MS, Neuhouser ML, Wright JL, Stott-Miller M, Stanford JL. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes & Control : Ccc. 24: 1947-54. PMID 23907772 DOI: 10.1007/s10552-013-0270-5 |
0.579 |
|
| 2013 |
Fitzgerald LM, Kumar A, Boyle EA, Zhang Y, McIntosh LM, Kolb S, Stott-Miller M, Smith T, Karyadi DM, Ostrander EA, Hsu L, Shendure J, Stanford JL. Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1520-8. PMID 23833122 DOI: 10.1158/1055-9965.Epi-13-0345 |
0.594 |
|
| 2013 |
Wright JL, Plymate S, D'Oria-Cameron A, Bain C, Haugk K, Xiao L, Lin DW, Stanford JL, McTiernan A. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial. The Prostate. 73: 1345-51. PMID 23775525 DOI: 10.1002/Pros.22682 |
0.43 |
|
| 2013 |
Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Annals of Internal Medicine. 158: 709-17. PMID 23689764 DOI: 10.7326/0003-4819-158-10-201305210-00005 |
0.545 |
|
| 2013 |
Geybels MS, Wright JL, Holt SK, Kolb S, Feng Z, Stanford JL. Statin use in relation to prostate cancer outcomes in a population-based patient cohort study. The Prostate. 73: 1214-22. PMID 23633265 DOI: 10.1002/Pros.22671 |
0.57 |
|
| 2013 |
Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, Hamilton AS, Potosky AL, Stanford JL, Stroup AM, Penson DF. Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. Journal of the National Cancer Institute. 105: 711-8. PMID 23615689 DOI: 10.1093/Jnci/Djt059 |
0.466 |
|
| 2013 |
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russell R, Russel R, Dunning AM, Luccarini C, Dennis J, ... ... Stanford JL, et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Human Molecular Genetics. 22: 2520-8. PMID 23535824 DOI: 10.1093/Hmg/Ddt086 |
0.53 |
|
| 2013 |
Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, ... ... Stanford JL, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics. 45: 385-91, 391e1-2. PMID 23535732 DOI: 10.1038/Ng.2560 |
0.655 |
|
| 2013 |
Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, ... ... Stanford JL, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013: 560857. PMID 23476788 DOI: 10.1155/2013/560857 |
0.445 |
|
| 2013 |
Geybels MS, Neuhouser ML, Stanford JL. Associations of tea and coffee consumption with prostate cancer risk. Cancer Causes & Control : Ccc. 24: 941-8. PMID 23412806 DOI: 10.1007/s10552-013-0170-8 |
0.621 |
|
| 2013 |
Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Long-term functional outcomes after treatment for localized prostate cancer. The New England Journal of Medicine. 368: 436-45. PMID 23363497 DOI: 10.1056/Nejmoa1209978 |
0.324 |
|
| 2013 |
Stott-Miller M, Neuhouser ML, Stanford JL. Consumption of deep-fried foods and risk of prostate cancer. The Prostate. 73: 960-9. PMID 23335051 DOI: 10.1002/pros.22643 |
0.539 |
|
| 2013 |
Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. The Journal of Urology. 189: S2-S11. PMID 23234625 DOI: 10.1016/j.juro.2012.11.014 |
0.554 |
|
| 2013 |
Geybels MS, Hutter CM, Kwon EM, Ostrander EA, Fu R, Feng Z, Stanford JL, Peters U. Variation in selenoenzyme genes and prostate cancer risk and survival. The Prostate. 73: 734-42. PMID 23143801 DOI: 10.1002/Pros.22617 |
0.603 |
|
| 2013 |
Taioli E, Sears V, Watson A, Flores-Obando RE, Jackson MD, Ukoli FA, de Syllos Cólus IM, Fernandez P, McFarlane-Anderson N, Ostrander EA, Rodrigues IS, Stanford JL, Taylor JA, Tulloch-Reid M, Ragin CC. Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent. The Prostate. 73: 668-76. PMID 23129512 DOI: 10.1002/Pros.22612 |
0.565 |
|
| 2013 |
Stott-Miller M, Karyadi DM, Smith T, Kwon EM, Kolb S, Stanford JL, Ostrander EA. HOXB13 mutations in a population-based, case-control study of prostate cancer. The Prostate. 73: 634-41. PMID 23129385 DOI: 10.1002/Pros.22604 |
0.468 |
|
| 2013 |
Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, ... ... Stanford JL, et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics. 22: 408-15. PMID 23065704 DOI: 10.1093/Hmg/Dds425 |
0.467 |
|
| 2013 |
Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, et al. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 132: 5-14. PMID 23064873 DOI: 10.1007/S00439-012-1229-4 |
0.616 |
|
| 2013 |
FitzGerald LM, Zhang X, Kolb S, Kwon EM, Liew YC, Hurtado-Coll A, Knudsen BS, Ostrander EA, Stanford JL. Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression. Human Mutation. 34: 149-56. PMID 22887727 DOI: 10.1002/Humu.22176 |
0.379 |
|
| 2013 |
Wright JL, Lin DW, Stanford JL. Reply to circumcision unlikely to be associated with prostate cancer risk. Cancer. 119: 246. PMID 22744887 DOI: 10.1002/cncr.27714 |
0.641 |
|
| 2013 |
Liang Y, Ankerst DP, Feng Z, Fu R, Stanford JL, Thompson IM. The risk of biopsy-detectable prostate cancer using the prostate cancer prevention trial risk calculator in a community setting Urologic Oncology: Seminars and Original Investigations. 31: 1464-1469. PMID 22552047 DOI: 10.1016/J.Urolonc.2012.03.012 |
0.597 |
|
| 2013 |
Holt SK, Kwon EM, Fu R, Kolb S, Feng Z, Ostrander EA, Stanford JL. Association of variants in estrogen-related pathway genes with prostate cancer risk Prostate. 73: 1-10. PMID 22549291 DOI: 10.1002/Pros.22534 |
0.604 |
|
| 2013 |
Wright J, Chery L, Lin D, Holt S, Luedeke M, Rinckleb A, Maier C, Stanford J. 2139 ASPIRIN USE REDUCES RISK OF TMPRSS2:ERG FUSION POSITIVE PROSTATE CANCER Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2048 |
0.657 |
|
| 2013 |
Resnick M, Barocas D, Morgans A, Phillips S, Fan K, Koyama T, Albertsen P, Chen V, Cooperberg M, Graff J, Greenfield S, Hamilton A, Hoffman K, Hoffman R, Kaplan S, ... Stanford J, et al. 449 THE BURDEN OF PRE-TREATMENT URINARY, SEXUAL, AND BOWEL DYSFUNCTION ACROSS TWO DECADES OF PROSTATE CANCER: RESULTS FROM PCOS AND CEASAR Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1839 |
0.395 |
|
| 2012 |
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, ... ... Stanford JL, et al. Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. Bmc Medical Genetics. 13: 46. PMID 22712434 DOI: 10.1186/1471-2350-13-46 |
0.505 |
|
| 2012 |
Kwon EM, Holt SK, Fu R, Kolb S, Williams G, Stanford JL, Ostrander EA. Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiology. 36: 347-53. PMID 22542949 DOI: 10.1016/J.Canep.2012.04.002 |
0.566 |
|
| 2012 |
White TA, Kwon EM, Fu R, Lucas JM, Ostrander EA, Stanford JL, Nelson PS. The monoamine oxidase A gene promoter repeat and prostate cancer risk. The Prostate. 72: 1622-7. PMID 22473857 DOI: 10.1002/Pros.22515 |
0.556 |
|
| 2012 |
Wright JL, Lin DW, Stanford JL. Circumcision and the risk of prostate cancer. Cancer. 118: 4437-43. PMID 22411189 DOI: 10.1002/cncr.26653 |
0.562 |
|
| 2012 |
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, et al. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Human Genetics. 131: 1095-103. PMID 22198737 DOI: 10.1007/S00439-011-1136-0 |
0.537 |
|
| 2012 |
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, ... ... Stanford JL, et al. Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. The Prostate. 72: 410-26. PMID 21748754 DOI: 10.1002/Pros.21443 |
0.427 |
|
| 2012 |
Hoffman R, Koyama T, Fan K, Albertsen P, Goodman M, Hamilton A, Stanford J, Stroup A, Penson D. 686 Survival Outcomes Following Surgery Or Radiation For Localized Prostate Cancer Results From The Prostate Cancer Outcomes Study The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.769 |
0.574 |
|
| 2012 |
Resnick M, Fan K, Koyama T, Albertsen P, Goodman M, Hamilton A, Hoffman R, Stanford J, Stroup A, Penson D. 653 Long Term Quality Of Life Outcomes Following Treatment For Clinically Localized Prostate Cancer: Results From The Prostate Cancer Outcomes Study The Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.733 |
0.582 |
|
| 2011 |
Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, Wiklund F, Stattin P, Isaacs WB, Xu J, Ostrander EA, Feng Z, Grönberg H, Stanford JL. Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1928-36. PMID 21846818 DOI: 10.1158/1055-9965.Epi-11-0236 |
0.616 |
|
| 2011 |
Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, ... ... Stanford JL, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics. 43: 785-91. PMID 21743467 DOI: 10.1038/Ng.882 |
0.58 |
|
| 2011 |
Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, ... ... Stanford JL, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32: 1361-5. PMID 21705483 DOI: 10.1093/Carcin/Bgr119 |
0.624 |
|
| 2011 |
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Chanock SJ, Kolb S, Signorello LB, et al. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. Plos Genetics. 7: e1001387. PMID 21637779 DOI: 10.1371/Journal.Pgen.1001387 |
0.647 |
|
| 2011 |
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nature Genetics. 43: 570-3. PMID 21602798 DOI: 10.1038/Ng.839 |
0.599 |
|
| 2011 |
Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, ... Stanford JL, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Research. 71: 3442-6. PMID 21558387 DOI: 10.1158/0008-5472.Can-11-0314 |
0.577 |
|
| 2011 |
FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1196-203. PMID 21467234 DOI: 10.1158/1055-9965.Epi-10-1299 |
0.61 |
|
| 2011 |
Wright JL, Lin DW, Stanford JL. The effect of demographic and clinical factors on the relationship between BMI and PSA levels. The Prostate. 71: 1631-7. PMID 21432865 DOI: 10.1002/pros.21380 |
0.375 |
|
| 2011 |
Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 923-33. PMID 21430300 DOI: 10.1158/1055-9965.Epi-10-0994 |
0.784 |
|
| 2011 |
Fesinmeyer MD, Kwon EM, Fu R, Ostrander EA, Stanford JL. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study. The Prostate. 71: 1538-47. PMID 21360564 DOI: 10.1002/Pros.21370 |
0.605 |
|
| 2011 |
Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Mittal RD, Isaacs WB, Platz EA, Hayes RB. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1075-81. PMID 21343373 DOI: 10.1158/1078-0432.Ccr-10-0881 |
0.67 |
|
| 2011 |
Wright JL, Kwon EM, Ostrander EA, Montgomery RB, Lin DW, Vessella R, Stanford JL, Mostaghel EA. Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 619-27. PMID 21266523 DOI: 10.1158/1055-9965.Epi-10-1023 |
0.577 |
|
| 2011 |
Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, ... ... Stanford JL, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 23-32. PMID 21071540 DOI: 10.1158/1055-9965.Epi-10-0698 |
0.614 |
|
| 2011 |
Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF. Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. Bju International. 107: 1223-31. PMID 21070583 DOI: 10.1111/j.1464-410X.2010.09861.x |
0.438 |
|
| 2011 |
Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, Stanford JL. AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. The Prostate. 71: 498-506. PMID 20945498 DOI: 10.1002/Pros.21267 |
0.529 |
|
| 2010 |
Salinas CA, Kwon EM, FitzGerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL. Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. American Journal of Epidemiology. 172: 578-90. PMID 20688905 DOI: 10.1093/Aje/Kwq175 |
0.808 |
|
| 2010 |
Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL. Vitamin D pathway gene variants and prostate cancer prognosis. The Prostate. 70: 1448-60. PMID 20687218 DOI: 10.1002/Pros.21180 |
0.374 |
|
| 2010 |
Johanneson B, McDonnell SK, Karyadi DM, Quignon P, McIntosh L, Riska SM, FitzGerald LM, Johnson G, Deutsch K, Williams G, Tillmans LS, Stanford JL, Schaid DJ, Thibodeau SN, Ostrander EA. Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus. Human Molecular Genetics. 19: 3852-62. PMID 20631155 DOI: 10.1093/Hmg/Ddq283 |
0.513 |
|
| 2010 |
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL. CYP17 polymorphisms and prostate cancer outcomes. The Prostate. 70: 1094-101. PMID 20503394 DOI: 10.1002/Pros.21143 |
0.591 |
|
| 2010 |
Fitzgerald LM, McDonnell SK, Carlson EE, Langeberg W, McIntosh LM, Deutsch K, Ostrander EA, Schaid DJ, Stanford JL. Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14. European Journal of Human Genetics : Ejhg. 18: 1141-7. PMID 20407467 DOI: 10.1038/Ejhg.2010.49 |
0.741 |
|
| 2010 |
Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange PH, Lin DW. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. The Journal of Urology. 183: 2213-8. PMID 20399459 DOI: 10.1016/j.juro.2010.02.017 |
0.593 |
|
| 2010 |
Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, ... ... Stanford JL, et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. The Prostate. 70: 735-44. PMID 20333727 DOI: 10.1002/Pros.21106 |
0.447 |
|
| 2010 |
Langeberg WJ, Tahir SA, Feng Z, Kwon EM, Ostrander EA, Thompson TC, Stanford JL. Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes. The Prostate. 70: 1020-35. PMID 20209490 DOI: 10.1002/Pros.21137 |
0.808 |
|
| 2010 |
Wright JL, Page ST, Lin DW, Stanford JL. Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiology. 34: 131-5. PMID 20206591 DOI: 10.1016/j.canep.2010.02.003 |
0.539 |
|
| 2010 |
Holt SK, Kwon EM, Lin DW, Ostrander EA, Stanford JL. Association of hepsin gene variants with prostate cancer risk and prognosis. The Prostate. 70: 1012-9. PMID 20166135 DOI: 10.1002/Pros.21135 |
0.625 |
|
| 2010 |
Langeberg WJ, Kwon EM, Koopmeiners JS, Ostrander EA, Stanford JL. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 258-64. PMID 20056646 DOI: 10.1158/1055-9965.Epi-09-0800 |
0.823 |
|
| 2010 |
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control : Ccc. 21: 289-300. PMID 19902366 DOI: 10.1007/S10552-009-9461-5 |
0.716 |
|
| 2009 |
Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Research. 69: 9315-22. PMID 19934327 DOI: 10.1158/0008-5472.Can-09-0648 |
0.491 |
|
| 2009 |
Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. The Journal of Urology. 182: 2702-7. PMID 19836772 DOI: 10.1016/J.Juro.2009.08.026 |
0.788 |
|
| 2009 |
Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. The Journal of Urology. 182: 2232-41. PMID 19781717 DOI: 10.1016/j.juro.2009.07.093 |
0.554 |
|
| 2009 |
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450 |
0.538 |
|
| 2009 |
Wright JL, Stanford JL. Metformin use and prostate cancer in Caucasian men: Results from a population-based case-control study Cancer Causes and Control. 20: 1617-1622. PMID 19653109 DOI: 10.1007/s10552-009-9407-y |
0.498 |
|
| 2009 |
Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL. Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1929-33. PMID 19454612 DOI: 10.1158/1055-9965.Epi-09-0113 |
0.499 |
|
| 2009 |
Fesinmeyer MD, Stanford JL, Brentnall TA, Mandelson MT, Farin FM, Srinouanprachanh S, Afsharinejad Z, Goodman GE, Barnett MJ, Austin MA. Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study. Pancreas. 38: 631-7. PMID 19436234 DOI: 10.1097/Mpa.0B013E3181A53Ef9 |
0.373 |
|
| 2009 |
Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3231-7. PMID 19366831 DOI: 10.1158/1078-0432.Ccr-08-2190 |
0.795 |
|
| 2009 |
Penney KL, Salinas CA, Pomerantz M, Schumacher FR, Beckwith CA, Lee GS, Oh WK, Sartor O, Ostrander EA, Kurth T, Ma J, Mucci L, Stanford JL, Kantoff PW, Hunter DJ, et al. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3223-30. PMID 19366828 DOI: 10.1158/1078-0432.Ccr-08-2733 |
0.78 |
|
| 2009 |
Harris JN, Bowen DJ, Kuniyuki A, McIntosh L, FitzGerald LM, Ostrander EA, Stanford JL. Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 11: 344-55. PMID 19346959 DOI: 10.1097/Gim.0B013E31819B2425 |
0.515 |
|
| 2009 |
Pierce BL, Biggs ML, Decambre M, Reiner AP, Li C, Fitzpatrick A, Carlson CS, Stanford JL, Austin MA. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older Cancer Causes and Control. 20: 1193-1203. PMID 19267250 DOI: 10.1007/S10552-009-9320-4 |
0.404 |
|
| 2009 |
Stanford JL, FitzGerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K, Hood L, Ostrander EA, Schaid DJ. Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage. Human Molecular Genetics. 18: 1839-48. PMID 19251732 DOI: 10.1093/Hmg/Ddp100 |
0.471 |
|
| 2009 |
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The Prostate. 69: 363-72. PMID 19058137 DOI: 10.1002/Pros.20887 |
0.813 |
|
| 2008 |
Holt SK, Salinas CA, Stanford JL. Vasectomy and the risk of prostate cancer. The Journal of Urology. 180: 2565-7; discussion 2. PMID 18930503 DOI: 10.1016/J.Juro.2008.08.042 |
0.81 |
|
| 2008 |
Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery E, Barry MJ. Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up. Journal of General Internal Medicine. 23: 1809-14. PMID 18795372 DOI: 10.1007/s11606-008-0785-8 |
0.545 |
|
| 2008 |
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Donovan J, Hamdy F, Cox A, Maier C, Vogel W, et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2052-61. PMID 18708398 DOI: 10.1158/1055-9965.Epi-08-0317 |
0.794 |
|
| 2008 |
FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME, Ostrander EA, Stanford JL, Huntsman DG. Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. Bmc Cancer. 8: 230. PMID 18694509 DOI: 10.1186/1471-2407-8-230 |
0.593 |
|
| 2008 |
Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA, Aloyz R, Nelson PS, Hood L, Narod SA, White KA, ... ... Stanford JL, et al. Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer Letters. 270: 173-80. PMID 18571837 DOI: 10.1016/J.Canlet.2008.05.006 |
0.528 |
|
| 2008 |
Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3823-31. PMID 18559602 DOI: 10.1158/1078-0432.Ccr-07-4566 |
0.539 |
|
| 2008 |
Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. American Journal of Epidemiology. 168: 250-60. PMID 18556686 DOI: 10.1093/Aje/Kwn141 |
0.754 |
|
| 2008 |
Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1203-13. PMID 18483343 DOI: 10.1158/1055-9965.Epi-07-2811 |
0.768 |
|
| 2008 |
Pierce BL, Plymate S, Ostrander EA, Stanford JL. Diabetes mellitus and prostate cancer risk. The Prostate. 68: 1126-32. PMID 18459104 DOI: 10.1002/Pros.20777 |
0.511 |
|
| 2008 |
Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. The Journal of Urology. 179: S40-4. PMID 18405749 DOI: 10.1016/J.Juro.2008.03.136 |
0.303 |
|
| 2008 |
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. The Prostate. 68: 740-7. PMID 18302196 DOI: 10.1002/Pros.20732 |
0.585 |
|
| 2008 |
Johanneson B, McDonnell SK, Karyadi DM, Hebbring SJ, Wang L, Deutsch K, McIntosh L, Kwon EM, Suuriniemi M, Stanford JL, Schaid DJ, Ostrander EA, Thibodeau SN. Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. Human Genetics. 123: 65-75. PMID 18066601 DOI: 10.1007/S00439-007-0451-Y |
0.514 |
|
| 2008 |
Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1990-9. PMID 17932346 DOI: 10.1158/1055-9965.Epi-07-0487 |
0.615 |
|
| 2008 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes & Control : Ccc. 19: 25-31. PMID 17906959 DOI: 10.1007/S10552-007-9066-9 |
0.539 |
|
| 2008 |
Penson DF, Hamilton A, Alonzo T, Lo M, Hoffman R, Potosky A, Stanford J. Secondary Therapy In Localized Prostate Cancer: Results From The Prostate Cancer Outcomes Study Urotoday International Journal. 1. DOI: 10.3834/Uij.1939-4810.2008.09.15 |
0.641 |
|
| 2007 |
Agalliu I, Weiss NS, Lin DW, Stanford JL. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Cancer Causes & Control : Ccc. 18: 931-7. PMID 17641982 DOI: 10.1016/J.Juro.2007.10.044 |
0.547 |
|
| 2007 |
Schaid DJ, Stanford JL, McDonnell SK, Suuriniemi M, McIntosh L, Karyadi DM, Carlson EE, Deutsch K, Janer M, Hood L, Ostrander EA. Genome-wide linkage scan of prostate cancer Gleason score and confirmation of chromosome 19q. Human Genetics. 121: 729-35. PMID 17486369 DOI: 10.1007/S00439-007-0368-5 |
0.551 |
|
| 2007 |
Langeberg WJ, Isaacs WB, Stanford JL. Genetic etiology of hereditary prostate cancer. Frontiers in Bioscience : a Journal and Virtual Library. 12: 4101-10. PMID 17485361 DOI: 10.2741/2374 |
0.796 |
|
| 2007 |
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, ... ... Stanford JL, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Human Molecular Genetics. 16: 1271-8. PMID 17478474 DOI: 10.1093/Hmg/Ddm075 |
0.44 |
|
| 2007 |
Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, Stanford JL, Ostrander EA. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 809-14. PMID 17416775 DOI: 10.1158/1055-9965.Epi-06-1049 |
0.653 |
|
| 2007 |
Johanneson B, Deutsch K, McIntosh L, Friedrichsen-Karyadi DM, Janer M, Kwon EM, Iwasaki L, Hood L, Ostrander EA, Stanford JL. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer. The Prostate. 67: 732-42. PMID 17372923 DOI: 10.1002/Pros.20528 |
0.479 |
|
| 2007 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 109: 1192-202. PMID 17311344 DOI: 10.1002/Cncr.22534 |
0.572 |
|
| 2007 |
Agalliu I, Kwon EM, Zadory D, McIntosh L, Thompson J, Stanford JL, Ostrander EA. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 839-43. PMID 17289875 DOI: 10.1158/1078-0432.Ccr-06-2164 |
0.55 |
|
| 2007 |
Pierce BL, Friedrichsen-Karyadi DM, McIntosh L, Deutsch K, Hood L, Ostrander EA, Austin MA, Stanford JL. Genomic scan of 12 hereditary prostate cancer families having an occurrence of pancreas cancer. The Prostate. 67: 410-5. PMID 17192958 DOI: 10.1002/Pros.20527 |
0.6 |
|
| 2007 |
Ostrander EA, Kwon EM, Stanford JL. Genetic susceptibility to aggressive prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1761-4. PMID 17035380 DOI: 10.1158/1055-9965.Epi-06-0730 |
0.532 |
|
| 2006 |
Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, ... ... Stanford JL, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Human Genetics. 120: 471-85. PMID 16932970 DOI: 10.1007/s00439-006-0219-9 |
0.588 |
|
| 2006 |
Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. The Prostate. 66: 1535-41. PMID 16921513 DOI: 10.1002/Pros.20491 |
0.778 |
|
| 2006 |
Salinas CA, Agalliu I, Stanford JL, Lin DW. Statins and the risk of cancer. Jama. 295: 2721; author reply 2. PMID 16788124 DOI: 10.1001/Jama.295.23.2721-A |
0.718 |
|
| 2006 |
Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. The American Journal of Medicine. 119: 418-25. PMID 16651054 DOI: 10.1016/j.amjmed.2005.06.072 |
0.506 |
|
| 2006 |
Porter MP, Stanford JL, Lange PH. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening. The Prostate. 66: 1044-51. PMID 16598738 DOI: 10.1002/PROS.20417 |
0.512 |
|
| 2006 |
Stanford JL, McDonnell SK, Friedrichsen DM, Carlson EE, Kolb S, Deutsch K, Janer M, Hood L, Ostrander EA, Schaid DJ. Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. The Prostate. 66: 317-25. PMID 16245279 DOI: 10.1002/Pros.20349 |
0.583 |
|
| 2006 |
Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. The Prostate. 66: 146-56. PMID 16173036 DOI: 10.1002/Pros.20305 |
0.808 |
|
| 2005 |
Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. The Journal of Urology. 174: 646-50; discussion 6. PMID 16006930 DOI: 10.1097/01.Ju.0000165342.85300.14 |
0.53 |
|
| 2005 |
Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, ... ... Stanford JL, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. American Journal of Human Genetics. 77: 219-29. PMID 15988677 DOI: 10.1086/432377 |
0.422 |
|
| 2005 |
Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. The Journal of Urology. 173: 1701-5. PMID 15821561 DOI: 10.1097/01.Ju.0000154637.38262.3A |
0.303 |
|
| 2005 |
Salinas CA, Austin MA, Ostrander EO, Stanford JL. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. The Prostate. 65: 58-65. PMID 15810021 DOI: 10.1002/Pros.20230 |
0.799 |
|
| 2005 |
Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 26: 1368-73. PMID 15802297 DOI: 10.1093/Carcin/Bgi085 |
0.442 |
|
| 2005 |
Friedrichsen DM, Hawley S, Shu J, Humphrey M, Sabacan L, Iwasaki L, Etzioni R, Ostrander EA, Stanford JL. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. The Prostate. 65: 44-51. PMID 15800934 DOI: 10.1002/Pros.20259 |
0.448 |
|
| 2005 |
Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, Hod E, Katz A, Isaacs WB, Hebbring S, Komiya A, McDonnell SK, Wiley KE, Jacobsen SJ, Isaacs SD, Walsh PC, ... ... Stanford JL, et al. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Research. 65: 1213-22. PMID 15735005 DOI: 10.1158/0008-5472.Can-04-4249 |
0.636 |
|
| 2005 |
Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, ... ... Stanford JL, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Journal of the National Cancer Institute. 97: 94-102. PMID 15657339 DOI: 10.1093/jnci/dji009 |
0.444 |
|
| 2005 |
Porter MP, Stanford JL. Obesity and the risk of prostate cancer. The Prostate. 62: 316-21. PMID 15389806 DOI: 10.1002/PROS.20121 |
0.552 |
|
| 2005 |
Schoonen WM, Salinas CA, Kiemeney LA, Stanford JL. Alcohol consumption and risk of prostate cancer in middle-aged men. International Journal of Cancer. 113: 133-40. PMID 15386436 DOI: 10.1002/ijc.20528 |
0.777 |
|
| 2004 |
Rothman I, Stanford JL, Kuniyuki A, Berger RE. Self-report of prostatitis and its risk factors in a random sample of middle-aged men. Urology. 64: 876-9; discussion 87. PMID 15533468 DOI: 10.1016/j.urology.2004.06.071 |
0.515 |
|
| 2004 |
Ostrander EA, Markianos K, Stanford JL. Finding prostate cancer susceptibility genes. Annual Review of Genomics and Human Genetics. 5: 151-75. PMID 15485346 DOI: 10.1146/Annurev.Genom.5.061903.180044 |
0.512 |
|
| 2004 |
Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL, Albertsen PC, Hamilton AS. Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4193-201. PMID 15483030 DOI: 10.1200/Jco.2004.09.127 |
0.482 |
|
| 2004 |
Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Journal of the National Cancer Institute. 96: 1358-67. PMID 15367568 DOI: 10.1093/jnci/djh259 |
0.553 |
|
| 2004 |
Kristal AR, Stanford JL. Cruciferous vegetables and prostate cancer risk: Confounding by PSA screening Cancer Epidemiology Biomarkers and Prevention. 13: 1265. PMID 15247142 |
0.579 |
|
| 2004 |
Cheteri MB, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, Langlois MC, Feng Z, Ostrander EA. Vitamin D receptor gene polymorphisms and prostate cancer risk. The Prostate. 59: 409-18. PMID 15065089 DOI: 10.1002/Pros.20001 |
0.634 |
|
| 2004 |
Lubieniecka JM, Cheteri MK, Stanford JL, Ostrander EA. Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study. The Prostate. 59: 357-9. PMID 15065083 DOI: 10.1002/Pros.20005 |
0.518 |
|
| 2004 |
Friedrichsen DM, Stanford JL, Isaacs SD, Janer M, Chang BL, Deutsch K, Gillanders E, Kolb S, Wiley KE, Badzioch MD, Zheng SL, Walsh PC, Jarvik GP, Hood L, Trent JM, et al. Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families. Proceedings of the National Academy of Sciences of the United States of America. 101: 1939-44. PMID 14769943 DOI: 10.1073/Pnas.0308336100 |
0.58 |
|
| 2004 |
Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 604-9. PMID 12869398 |
0.481 |
|
| 2003 |
Janer M, Friedrichsen DM, Stanford JL, Badzioch MD, Kolb S, Deutsch K, Peters MA, Goode EL, Welti R, DeFrance HB, Iwasaki L, Li S, Hood L, Ostrander EA, Jarvik GP. Genomic scan of 254 hereditary prostate cancer families. The Prostate. 57: 309-19. PMID 14601027 DOI: 10.1002/Pros.10305 |
0.419 |
|
| 2003 |
Stanford JL, Sabacan LP, Noonan EA, Iwasaki L, Shu J, Feng Z, Ostrander EA. Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 876-81. PMID 14504198 |
0.623 |
|
| 2003 |
Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 763-8. PMID 12917208 |
0.473 |
|
| 2003 |
Conlon EM, Goode EL, Gibbs M, Stanford JL, Badzioch M, Janer M, Kolb S, Hood L, Ostrander EA, Jarvik GP, Wijsman EM. Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset International Journal of Cancer. 105: 630-635. PMID 12740911 DOI: 10.1002/Ijc.11128 |
0.545 |
|
| 2003 |
Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 1147-54. PMID 12637483 DOI: 10.1200/Jco.2003.07.139 |
0.456 |
|
| 2003 |
Habel LA, Zhao W, Stanford JL. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes & Control : Ccc. 13: 427-34. PMID 12146847 DOI: 10.1023/A:1015788502099 |
0.606 |
|
| 2002 |
Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW, Coates RJ, Liff JM, Talamini R, Chantarakul N, Koetsawang S, Rachawat D, Morabia A, Schuman L, Stewart W, ... ... Stanford JL, et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. British Journal of Cancer. 87: 1234-45. PMID 12439712 DOI: 10.1038/Sj.Bjc.6600596 |
0.327 |
|
| 2002 |
Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. Bmj (Clinical Research Ed.). 325: 740. PMID 12364300 DOI: 10.1136/bmj.325.7367.740 |
0.535 |
|
| 2002 |
Kristal AR, Cohen JH, Qu P, Stanford JL. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 719-25. PMID 12163324 |
0.389 |
|
| 2002 |
Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, Albertsen PC, Gilliland FD, Stanford JL. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. Journal of the National Cancer Institute. 94: 430-7. PMID 11904315 DOI: 10.1093/Jnci/94.6.430 |
0.439 |
|
| 2002 |
Stanford JL, Noonan EA, Iwasaki L, Kolb S, Chadwick RB, Feng Z, Ostrander EA. A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 243-7. PMID 11895872 |
0.491 |
|
| 2002 |
Hsu L, Prentice RL, Stanford JL. Some further results on incorporating risk factor information in assessing the dependence between paired failure times arising from case-control family studies: An application to prostate cancer Statistics in Medicine. 21: 863-876. PMID 11870822 DOI: 10.1002/Sim.1055 |
0.329 |
|
| 1989 |
Stanford J, Brinton L, Hoover R. Oral contraceptives and breast cancer: results from an expanded case-control study. British Journal of Cancer. 60: 375-381. PMID 2789945 DOI: 10.1038/Bjc.1989.288 |
0.403 |
|
| Show low-probability matches. |